Used in scientific research to study nicotinic acetylcholine receptors due to its high affinity for these receptor sites. Its structural similarity to nicotine allows it to bind to these receptors and act as an agonist or partial agonist. It serves as a pharmacological tool to understand receptor function, neurotransmission mechanisms in the nervous system, including effects on neurotransmitters such as dopamine and norepinephrine. Valuable in behavioral and neurochemical studies, including addiction, learning, and memory.

Also investigated for potential use in developing treatments for neurological disorders such as Alzheimer's disease, Parkinson's disease, depression, and nicotine addiction. Some studies suggest potential in smoking cessation by providing low-level stimulation to reduce withdrawal symptoms, though further research is needed for safety and efficacy.

Additionally, it has been explored in veterinary medicine as a respiratory stimulant in certain animal models.